CompletedNot Applicable

Effects of Vitamin D on Moderate to Severe Periodontitis

360 participantsStarted 2013-01

Plain-language summary

The object of the study was to evaluate the direct effect of high dose vitamin D supplementation on chronic periodontitis, and suggest the recommended dose for clinic use.

Who can participate

Age range30 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age from 30 years old to 70 years old
✓. More than 20 teeth remaining in the mouth
✓. Clinical diagnosis of moderate to severe periodontitis
✓. Not receiving periodontal treatment within 6 months
✓. Not taking antibiotic drugs within 3 months.

Exclusion criteria

✕. Diabetes, thyroid and parathyroid endocrine associated diseases
✕. Severe systemic diseases, such as cancer
✕. Taking vitamin D and / or calcium drugs during observation
✕. Taking aspirin, non-steroidal anti-inflammatory drugs, and steroids
✕. Pregnant or prepare to pregnant within one year
✕. Have been suffering from hypercalcemia, malabsorption syndrome.

What they're measuring

Attachment Loss (AL)

Timeframe: at baseline

Attachment Loss (AL)

Timeframe: 3 months after periodontal treatment

Attachment Loss (AL)

Timeframe: 6 months after periodontal treatment

Trial details

NCT IDNCT03044886

SponsorBeijing Chao Yang Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-12

Results submitted2017-11-12

View on ClinicalTrials.gov More Chronic Peritonitis trials